United Bank for Africa Plc has not published a single audited number since Q1 2026, and yet its shares continue to trade every day on the Nigerian Exchange. For a bank that claims to be Africa’s global bank, with operations in 20 African countries, London, Paris and New York, that is not a minor administrative delay, it is a breakdown in the basic contract between a listed company and its shareholders: you give us your capital, we give you timely, audited information to value it. As at early November 2026, investors are still valuing UBA on Q1 figures that are now more than seven months old, in which profit before tax had already fallen 21.4% to N160.66 billion and profit after tax had fallen 22.8% to N146.62 billion, while its peers have moved on to H1 and even 9-month numbers. The question is no longer when will UBA report, but what is it that the regulator does not want the market to see yet, and what will happen when it finally does.
The official reason for the delay is regulatory approval, not audit failure. UBA’s Board met on 13 August 2026 and approved the audited financial statements for the six months ended 30 June 2026, but the bank said publication was subject to receipt of approval from the Central Bank of Nigeria. The Nigerian Exchange then extended UBA’s filing deadline from the normal 60-day deadline of 29 August to 30 September 2026, and that extended deadline has also now been missed with no new date given. On 29 October 2026, the Board also approved its unaudited 9-month results to 30 September 2026, but said those too will be published together with the audited H1 results, pending CBN approval, and no figures were disclosed. UBA is not alone, Access Holdings and Fidelity Bank are in the same position, meaning investors are trading all three stocks on numbers that are now more than six months old, while GTCO and Zenith have since published H1 and First HoldCo has published 9-month pre-tax profit up 60.8% to N911.24 billion.
The deeper reason is that this is the first audited set since the industry’s recapitalisation, and the CBN has stepped up its review of banks’ asset quality, credit provisioning and foreign currency risk exposures. Reports point to a systemic effort to stress-test balance sheets against elevated loan impairments, capital adequacy requirements, and sovereign restructuring risks across pan-African subsidiaries before clearing interim audited accounts for public release. That matters because the CBN had earlier required certain banks under forbearance to suspend dividends until capital and provisioning conditions are met, and H1 is the point at which an interim dividend would normally be declared. UBA paid 25 kobo as interim dividend for H1 2025, but there is no guarantee of a payout this year if the CBN forces higher provisioning. In other words, the delay is not just about late paper, it is about whether UBA’s loan book, especially its restructured and foreign-currency loans, is properly provided for, and whether its capital is genuinely strong enough to pay a dividend.
The implications are already visible, and they are more serious than a missed deadline. First, price discovery is frozen. With the NGX Banking Index flat and the biggest banks silent, analysts say the delays have effectively frozen price discovery in one of the market’s most closely watched sectors. UBA’s share price rose only 2.14% from N42.10 on 2 January to N43.00 on 12 October, trailing peers that had reported, because investors cannot compare UBA with banks that have already shown their H1 and 9M numbers. Second, the delay creates suspicion even if there is no fault. Every week of silence allows the market to price in the worst case, higher impairments, tighter capital, no dividend, and on social media the mood has already turned to exasperation, with investors noting that banks have begun releasing Q3 results while UBA and Access have not yet released H1. Third, the insider trading window stays shut until 24 hours after publication, which reduces liquidity and signals that even insiders cannot act on the numbers they have already approved. Fourth, it damages the credibility of Nigeria’s disclosure regime itself, because the NGX wants 60-day filing, the CBN wants pre-clearance, and the two timetables clash with no public explanation of the approval queue, its scope, or its expected resolution.
The critical judgment is that UBA’s delay should be read as regulatory, but not innocent. The fact that the Board approved the accounts suggests the audit is complete, and the hold-up is CBN clearance. But the longer it drags, the more it looks like the regulator is using delay as a tool to force cleaning up before disclosure, and the more the market will punish UBA for the uncertainty. When UBA finally publishes H1 and 9M together, the market will not just look at profit, it will look at three numbers that will decide whether the delay was prudence or warning: impairment charge, non-performing loan ratio, and capital adequacy. If those are clean and an interim dividend is allowed, the delay will be forgiven. If they show a sharp deterioration from Q1’s already weak N160.66 billion pre-tax profit, with higher provisions wiping out earnings, the delay will be read in hindsight as an early warning that UBA was not ready to tell the market the truth about its loan book.
